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The rising cost of healthcare around the world is a source of increasing concern for many governments.1,2 Although there are 
many factors driving this trend at both the national and 
international levels, every doctor has a responsibility 
to justify ordering investigations and prescription 
medications. Patient demand and a consumerist 
approach to healthcare puts pressure on doctors to 
investigate and prescribe more; however, this may 
not always be in a patient’s best interests and can 
lead to overdiagnosis and the development of 
iatrogenic disease.3,4 
The National Health Service (NHS) in the UK has 
struggled with these problems for years and doctors 
working within the NHS—especially in primary 
care—have become increasingly aware of the predictive 
value of investigations and the cost-effectiveness of 
medical treatments.5 In Oman, doctors often want to 
offer, and patients increasingly expect to receive, the 
latest treatments and investigations. Although these 
are often more expensive, they are not always more 
effective; to this end, the World Health Organization 
(WHO) runs a programme promoting the rational use 
of medicines in countries where polypharmacy is a 
major problem.6
It is important that doctors in training have an 
appreciation of these financial issues in order to carry 
forward best medical practices. The UK and Omani 
governments both provide socialised comprehensive 
national health services to all citizens, free at the point 
of delivery.7,8 Additionally, in both countries, primary 
care physicians are the gateway to secondary care 
services and have easy access to blood tests, medical 
imaging and clinical physiology tests. Trainees in 
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abstract: Objectives: This audit aimed to investigate the use of prescription drugs and investigations by trainee 
doctors in primary care settings in Oman and the UK. Methods: This audit took place between February and April 
2015. The medical records of consecutive patients seen by five family medicine trainee doctors at a primary care 
setting in Oman were retrospectively reviewed. These data were compared to those gathered from two trainees at 
a general practice clinic in the UK as well as an experienced general practitioner (GP) who had practiced in both 
countries. Results: The average number of items prescribed per patient was 1.19, 0.43 and 0.24 and the rate of 
investigations was 20%, 21% and 11% for Omani trainees, UK trainees and the GP, respectively. Conclusion: This 
audit suggests that family medicine trainees in Oman prescribe almost three times as many drugs as trainees in the 
UK. The findings also point towards an over-investigation of the relatively young Omani patient population.
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امللخ�ص: الهدف: يهدف هذا البحث التدقيقي للتحقق من و�شف الأدوية والفحو�ش�ت عند املتدربني من اأطب�ء الرع�ية ال�شحية الأولية يف 
�شلطنة عم�ن واململكة املتحدة. الطريقة: اأجرى هذا البحث التدقيقي بني فرباير واأبريل من ع�م 2015م, حني مت فح�س ال�شجالت الطبية 
هذه  وقورنت  عم�ن.  يف  الأولية  ال�شحية  الرع�ية  عي�دات  يف  الأ�رسة  طب  تخ�ش�س  من  متدربني  اأطب�ء  خم�شة  ع�جلهم  الذين  للمر�شى 
املعلوم�ت بتلك التي جمعت من و�شف�ت متدربني اثنني بعي�دة طبية ع�مة يف اململكة املتحدة, ومن طبيب متمر�س م�ر�س املهنة يف 
الدولتني. النت�ئج: ك�ن متو�شط عدد الو�شف�ت التي اأعط�ه� الأطب�ء املتدربون يف عم�ن, ويف بريط�ني�, والطبيب املتمر�س لكل مري�س يف 
عم�ن هي 0.24 و 0.43, 1.19, وك�ن معدل طلب الفحو�ش�ت عند هوؤلء هو %11 و %21, %20, على التوايل. اخلال�شة: اأ�ش�ر هذا البحث 
التدقيقي اأن متدربي طب الأ�رسة يف عم�ن ي�شفون عددا من الأدوية اأكرث من نظرائهم يف بريط�ني� بنحو ثالث مرات. وي�شري البحث اأي�ش� 
اإىل الفراط يف طلب فحو�ش�ت للمر�شى العم�نيني ال�شغ�ر ال�شن ن�شبي�.
الكلمات املفتاحية: الو�شف�ت الطبية؛ املوارد الطبية؛ الرع�ية ال�شحية الأولية؛ عم�ن؛ اململكة املتحدة.
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both countries face similar challenges as they move 
from the disease-centred and systematic approach 
of hospital practice to a more patient-centred and 
focused approach in family medicine. This audit 
therefore aimed to compare the use of resources (i.e. 
prescription drugs and investigations) by trainee 
doctors in primary care settings in Oman and the UK.
Methods
This audit was carried out between February and 
April 2015. A retrospective review was conducted 
of the medical records of consecutively attending 
patients in February and March 2015 seen by five final 
year trainees at the Family & Community Medicine 
clinic of Sultan Qaboos University Hospital in Muscat, 
Oman. As there is no international benchmark for 
rates of prescription and investigations, these data 
were compared with those of two trainees from 
St Augustine’s Medical Practice, Bristol, UK, and 
an experienced general practitioner (GP) who had 
practised medicine in both Oman and the UK. The 
data from the UK trainees were collected in the same 
way and during the same time period as that of the 
Omani trainees. For the experienced GP, only data 
on patients seen in the UK in April 2015 were used in 
the analysis. 
The audit examined the number of items pres-
cribed per patient and the percentage of patients 
who underwent investigations for all three groups. 
The number and category of drugs prescribed was 
also analysed. Only patients presenting with medical 
conditions requiring same day consultations were 
included. Data for the three groups were compared 
using means and 95% confidence intervals (CIs).
Results 
Overall, the records of 347 patients were reviewed, 
including 102 patients (29%) seen by trainees in 
Oman, 190 patients (55%) seen by trainees in the UK 
and 55 patients (16%) seen by the experienced GP. The 
average age of patients seen by the Omani trainees was 
26.1 years compared to 46.9 years for patients seen by 
the UK trainees and 47.2 years for patients seen in the 
UK by the experienced GP. 
The Omani trainees prescribed a mean of 1.19 
items per patient (95% CI: 1.02–1.36) compared to 
0.43 items per patient (95% CI: 0.34–0.51) prescribed 
by trainees in the UK and 0.24 items per patient 
(95% CI: 0.12–0.35) prescribed by the experienced GP 
[Figure 1]. Investigations were carried out on 20% of 
patients (95% CI: 12–27%) seen by trainees in Oman 
compared with 21% of patients (95% CI: 15–27%) seen 
by trainees in the UK and 11% of patients (95% CI: 
2–20%) seen by the experienced GP [Figure 2]. Figure 3 
shows the percentage of drugs prescribed according to 
drug category for all three groups.
 
Figure 1: Mean number of items prescribed per patient 
by five trainee doctors in Oman, two trainee doctors 
in the UK and an experienced  general practitioner. The 
error bars indicate 95% confidence intervals.
GP = general practitioner.
 
Figure 3: Drugs prescribed by category by five trainee 
doctors in Oman, two trainee doctors in the UK and an 
experienced general practitioner.
GP = general practitioner; NSAIDs = non-steroidal anti-inflamm-
atory drugs; Rx = prescriptions; ORS = oral rehydration solutions.
 
Figure 2: Rate of investigations by five trainee doctors 
in Oman, two trainee doctors in the UK and an 
experienced general practitioner.
GP = general practitioner.
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Discussion
As might be expected, the current audit showed that 
the experienced GP had lower rates of prescriptions 
and investigations than either group of trainees. 
There was no significant difference in the rates of 
investigation between the two groups of trainees in 
the current audit, although the average age of patients 
in Oman was much lower, which might point to over-
investigation. Omani trainees prescribed almost three 
times as many drugs as UK trainees in the present 
audit. However, this finding needs to be interpreted 
with caution; although there are many similarities 
between primary care settings in Oman and the UK, 
it is important to recognise that prescription charges 
apply for certain patients or specific drugs in the UK.7 
Although these fees apply to only approximately 10% 
of prescriptions, it has led to an expectation that many 
symptomatic treatments can be purchased over-the-
counter by the patient from pharmacies, decreasing 
the pressure on the physician to prescribe such 
medications.9 Indeed, in the current audit, the majority 
of items prescribed in Oman were symptomatic 
treatments and most likely prescribed for self-limiting 
illnesses, while the rates of antibiotic prescribing were 
similar among all three groups.
Prescribing rates are collected and reported by 
the WHO; however, this includes long-term drugs 
used in the treatment of chronic diseases and thus 
cannot be used as an international standard.6 In 1989, 
Hogerzeil et al. reported that the number of drugs 
prescribed per patient ranged from 1.4–3.8 in 
developing countries and 1.3–2.2 in developed 
countries.10 In 2000, Kinnersley et al. measured the 
prescription and investigation practices of GPs from 
10 NHS practices; the findings indicated that the GPs 
prescribed an average of 0.61 items per patient and 
carried out investigations for approximately 10% of 
patients.11 Although not the primary objective of this 
research, this is the only study in the literature that 
can be regarded as a benchmark to compare with the 
findings of the current audit [Table 1].11 Within the 
Arab region, research from Iran in 2010 indicated a 
rate of 3.34 items prescribed per patient, while a study 
from Yemen in the same year reported a rate of 2.65 
items prescribed per patient.12,13 However, these data 
should be only regarded as indicative of possible trends 
as it is not entirely clear whether these studies were 
conducted in similar primary care populations.12,13
This audit suggests the overuse of some prescrip-
tion drugs by Omani trainees; moreover, the average 
age of the patients seen in Oman was much lower 
than that of the UK trainees or the experienced 
GP, indicating the existence of a younger patient 
population. Further formal comparative studies 
with larger sample sizes are required to explore the 
underlying reasons for the apparent over-prescription 
of certain drugs by trainees in Oman. Nevertheless, it 
is important to note that, although the health services 
available in Oman and the UK are similar, there are 
profound differences in lifestyle and culture. Patients’ 
understanding of health issues and their expectations 
of treatment are also very different; as such, there may 
be considerable pressure on young doctors in Oman to 
prescribe and investigate, sometimes inappropriately. 
There were several limitations to this audit. 
First, the number of trainees involved was small, as 
was the number of patients; this is especially true 
for the number of patients seen by the experienced 
GP, as senior doctors tend to have fewer same day 
consultations. Second, the data were gathered by 
individual doctors who manually reviewed the patients 
they had seen each day; therefore, the data may have 
been subject to errors and omissions. Automatic and 
electronic data collection systems would be likely to 
yield more reliable results.
Table 1: Comparison of prescription and investigation practices of trainee doctors in Oman and the UK and an 













UK trainees 2 190 46.9 0.43 21%
Omani trainees 5 102 26.1 1.19 20%
Experienced GP* 1 55 47.2 0.24 11%
Kinnersley et al.11 2000 10 NHS practices 711 30.0 0.61 10%
GP = general practitioner; NHS = National Health Services.
*With experience in both Oman and the UK.
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Conclusion
This simple audit suggests that family medicine 
trainees in Oman prescribe almost three times more 
drugs than GP trainees in the UK. Additionally, the 
findings seem to point towards the over-investigation 
of a much younger patient population in Oman. 
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